Literature DB >> 25337257

Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.

Peir-In Liang1, Sheng-Tsung Chang2, Ming-Yen Lin3, Yen-Chuan Hsieh4, Pei-Yi Chu5, Chih-Jung Chen6, Kai-Jen Lin7, Yun-Chih Jung8, Wei-Shou Hwang9, Wen-Tsung Huang10, Wei-Chin Chang11, Hongtao Ye12, Shih-Sung Chuang13.   

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma (PTCL) of follicular helper T-cell origin and is rare in Taiwan. There are overlapping features of AITL and peripheral T-cell lymphoma with a follicular growth pattern (PTCL-F). Around one fifth of PTCL-F exhibits t(5;9)(q33;q22)/ITK-SYK chromosomal translocation, which is essentially absent in AITL. We retrospectively investigated 35 cases of AITL from Taiwan with histopathology review, immunohistochemistry, in situ hybridization for Epstein-Barr virus (EBV) and fluorescence in situ hybridization (FISH) for t(5;9)(q33;q22)/ITK-SYK and correlated the results with overall survival. Twenty-six cases of not otherwise specified PTCL (PTCL-NOS) were also examined by FISH for comparison. Most AITL patients were male (69%) and elderly (median age at 67 years) with frequent bone marrow involvement (53%), high Ann Arbor stages (77%), and elevated serum lactate dehydrogenase (68%). Most cases (80%) showed a typical CD4+/CD8- phenotype and in 90% cases there were scattered EBV-positive B-cells (less than 10% cells). None of these cases showed t(5;9)(q33;q22)/ITK-SYK translocation by FISH. Gain of ITK and SYK gene was identified in 38% and 14% tumors, respectively, but both were not associated with overall survival. Performance status < 2 was associated with a better outcome but not the other clinicopathological factors. All PTCL-NOS cases were negative for ITK-SYK translocation with similar rates (38% and 12%, respectively) of gains at ITK and SYK loci as that of AITL. In this so far the largest series of AITL from Taiwan, we reported the clinicopathological features and FISH findings on ITK and SYK genes. We confirmed the absence of t(5;9)(q33;q22)/ITK-SYK translocation, which may serve as an additional differential diagnostic tool from PTCL-F when present. PTCL-NOS shared a similar pattern of ITK and SYK gains with AITL. More studies are warranted to elucidate the roles of SYK and ITK and other genes in the lymphomagenesis of AITL in Taiwan.

Entities:  

Keywords:  Angioimmunoblastic T-cell lymphoma; ITK; SYK; Taiwan; follicular T-cell lymphoma; follicular helper T-cell; peripheral T-cell lymphoma

Mesh:

Substances:

Year:  2014        PMID: 25337257      PMCID: PMC4203228     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors.

Authors:  Kong-Chao Chang; Guan-Cheng Huang; Dan Jones; Chao-Jung Tsao; J Yu-yun Lee; Ih-Jen Su
Journal:  Leuk Lymphoma       Date:  2004-07

2.  Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?

Authors:  Karen L Grogg; Ayoma D Attygalle; William R Macon; Ellen D Remstein; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2005-08-15       Impact factor: 22.113

3.  Aberrant immunoarchitecture distinguishes hyperplastic germinal centres in pattern 1 angioimmunoblastic T-cell lymphoma from reactive follicles.

Authors:  Leonard Hwan-Cheong Tan; Soo-Yong Tan
Journal:  Hematol Oncol       Date:  2013-11-19       Impact factor: 5.271

4.  Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.

Authors:  B Streubel; U Vinatzer; M Willheim; M Raderer; A Chott
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

5.  Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma.

Authors:  H J Ree; M E Kadin; M Kikuchi; Y H Ko; J Suzumiya; J H Go
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

6.  Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.

Authors:  Ming-Yuan Lee; Tran-Der Tan; An-Chen Feng; Mei-Ching Liu
Journal:  Am J Hematol       Date:  2006-08       Impact factor: 10.047

7.  Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms.

Authors:  S S Chuang; C N Lin; C Y Li
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

8.  T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute.

Authors:  David Lu; Ching-Nan Lin; Shih-Sung Chuang; Wei-Shou Hwang; Wen-Tsung Huang
Journal:  Leuk Lymphoma       Date:  2004-05

9.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Authors:  Laurence de Leval; David S Rickman; Caroline Thielen; Aurélien de Reynies; Yen-Lin Huang; Georges Delsol; Laurence Lamant; Karen Leroy; Josette Brière; Thierry Molina; Françoise Berger; Christian Gisselbrecht; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

10.  Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.

Authors:  Ayoma Deepthi Attygalle; Charalampia Kyriakou; Jehan Dupuis; Karen Lynne Grogg; Timothy Charles Diss; Andrew Charles Wotherspoon; Shih Sung Chuang; José Cabeçadas; Peter Gershon Isaacson; Ming-Qing Du; Philippe Gaulard; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2007-07       Impact factor: 6.394

View more
  11 in total

Review 1.  Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

Authors:  Russell James Hubbard Ryan; Ryan Alan Wilcox
Journal:  Hematol Oncol Clin North Am       Date:  2019-05-18       Impact factor: 3.722

2.  T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.

Authors:  Tianjiao Wang; Ye Lu; Avery Polk; Pinki Chowdhury; Carlos Murga-Zamalloa; Hiroshi Fujiwara; Koichiro Suemori; Niklas Beyersdorf; Alexandra C Hristov; Megan S Lim; Nathanael G Bailey; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2016-10-25       Impact factor: 12.531

Review 3.  Update on recurrent mutations in angioimmunoblastic T-cell lymphoma.

Authors:  Daniel Dai Yu; Jianzhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2021-12-15

Review 4.  Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Authors:  Adrien Krug; Gamze Tari; Aymen Saidane; Philippe Gaulard; Jean-Ehrland Ricci; François Lemonnier; Els Verhoeyen
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 5.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

Review 6.  A three-signal model of T-cell lymphoma pathogenesis.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-17       Impact factor: 10.047

7.  Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; Gina L Razidlo; Surendra Dasari; Yu Zeng; Guangzhen Hu; Ryan A Knudson; Patricia T Greipp; Jaime I Davila; Sarah H Johnson; Julie C Porcher; James B Smadbeck; Bruce W Eckloff; Daniel D Billadeau; Paul J Kurtin; Mark A McNiven; Brian K Link; Stephen M Ansell; James R Cerhan; Yan W Asmann; George Vasmatzis; Andrew L Feldman
Journal:  Blood       Date:  2016-06-13       Impact factor: 22.113

8.  Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.

Authors:  Hsiao-Wen Kao; Tung-Liang Lin; Lee-Yung Shih; Po Dunn; Ming-Chung Kuo; Yu-Shin Hung; Jin-Hou Wu; Tzung-Chih Tang; Hung Chang; Tseng-Tong Kuo; Che-Wei Ou; Po-Nan Wang
Journal:  Int J Hematol       Date:  2016-04-19       Impact factor: 2.319

9.  ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.

Authors:  Yalu Liu; Xiaogan Wang; Lijuan Deng; Lingyan Ping; Yunfei Shi; Wen Zheng; Ningjing Lin; Xiaopei Wang; Meifeng Tu; Yan Xie; Weiping Liu; Zhitao Ying; Chen Zhang; Zhengying Pan; Xi Wang; Ning Ding; Yuqin Song; Jun Zhu
Journal:  Cancer Cell Int       Date:  2019-02-14       Impact factor: 5.722

10.  Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile.

Authors:  Timothy Beer; Patrick Dorion
Journal:  Hematol Rep       Date:  2015-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.